News and Announcements
Trends & Developments in Life Sciences: Insights from Top Experts in Investment & Innovation
- Published March 28, 2023 5:18AM UTC
- Publisher Jade Miguel
- Categories Capital Insights
Covid-19 has highlighted the importance of health and spurred remarkable advancements in the Life Sciences & Genomics sector.
Join Leslie Chong, Hsien Hui Tong, Victoria Gordon, and Kelly Constable as they discuss the impact of Covid-19 on Life Sciences investment, current trends, and opportunities for the sector in the next 1-2 years.
Moderated by Glen Cross, Director of Horizon 3 Biotech Fund, this video is a must-watch for investors and innovators in the Life Sciences space.
#VentureCapital #Innovation #WholesaleInvestor
Capital Insights
A$5 trillion market Australians can see but cannot easily buy
Every asset class now carries artificial intelligence exposure, including the ones built to be defensive. Capital47’s argument is that every portfolio should have a diversification strategy. The problem with AI as a portfolio exposure is that it has stopped being a sector. Planned global spending on artificial intelligence is expected to run to US$8 trillion […]
The A$20.4 Million Inertia Trap: How Kepa Software Is Unlocking Value in Enterprise Capital Allocation
A government agency renewed the same maintenance decision nine years running, because auditing the original choice was deemed too expensive. When the portfolio was finally tested, A$20.4 million of low value spend was identified in a single year. Kepa Software’s capital governance platform was built to expose and eliminate precisely these boardroom blind spots. For […]
Forget the share price. SpaceX just published a map of the next five years.
Most coverage of SpaceX’s result focused on a 9.1% share price fall. That is noise. The signal is in the transcript: compute, power, bandwidth and demand over the next five years.
Backed By Leading Investment Groups and Family Offices
